Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting ...